FGFR2 alpha (IIIb), His, Human
FGFR2 Alpha (IIIb), His, Human

Immobilized FGFR2 alpha (IIIb), His, Human, His Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-FGFR2 (IIIb) Antibody, hFc Tag with the EC50 of 1.8ng/ml determined by ELISA.

FGFR2 Alpha (IIIb), His, Human

The purity of FGFR2 alpha (IIIb), His, Human is greater than 95% as determined by SEC-HPLC.

FGFR2 Alpha (IIIb), His, Human

FGFR2 alpha (IIIb), His, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%.

FGFR2 alpha (IIIb), His, Human

Four distinct genes encoding closely related FGF receptors, FGF R1 - 4, are known. All four genes for FGF Rs encode proteins with an N-terminal signal peptide, three immunoglobulin (Ig)-like domains, an acid-box region containing a run of acidic residues between the IgI and IgII domains, a transmembrane domain and the split tyrosine-kinase domain. Multiple forms of FGF R1 - 3 are generated by alternative splicing of the mRNAs. A frequent splicing event involving FGF R1 and 2 results in receptors containing all three Ig domains, referred to as the alpha isoform, or only IgII and IgIII, referred to as the beta isoform.
Z04254
¥80,213.00

Ask us a question
Product Introduction
Species Human
Protein Construction
FGFR2 alpha (IIIb) (Arg22-Glu378)
Accession # P21802-3		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 40.7 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 60-80 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • FGFR2 Alpha (IIIb), His, Human
    • FGFR2 Alpha (IIIb), His, Human

    Immobilized FGFR2 alpha (IIIb), His, Human, His Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-FGFR2 (IIIb) Antibody, hFc Tag with the EC50 of 1.8ng/ml determined by ELISA.

  • FGFR2 Alpha (IIIb), His, Human
    • FGFR2 Alpha (IIIb), His, Human

    The purity of FGFR2 alpha (IIIb), His, Human is greater than 95% as determined by SEC-HPLC.

  • FGFR2 Alpha (IIIb), His, Human
    • FGFR2 Alpha (IIIb), His, Human

    FGFR2 alpha (IIIb), His, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%.


Background
Target Background Four distinct genes encoding closely related FGF receptors, FGF R1 - 4, are known. All four genes for FGF Rs encode proteins with an N-terminal signal peptide, three immunoglobulin (Ig)-like domains, an acid-box region containing a run of acidic residues between the IgI and IgII domains, a transmembrane domain and the split tyrosine-kinase domain. Multiple forms of FGF R1 - 3 are generated by alternative splicing of the mRNAs. A frequent splicing event involving FGF R1 and 2 results in receptors containing all three Ig domains, referred to as the alpha isoform, or only IgII and IgIII, referred to as the beta isoform.
Synonyms FGF R2a; FGFR2 alpha; KGFR; CD332; BBDS; BEK; BFR-1; CEK3; CFD1; ECT1; JWS; K-SAM; KGFR; TK14; TK25; FLJ98662

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.